ArticleJournal of thoracic disease2022

Future prospects of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and surgery for non-small cell lung cancer.

Tatsuya Nagano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.